建議您使用以下瀏覽器觀看本網站,
以獲得最佳瀏覽效果。
09.04 2023
Antibodies for T-Cell Activation (T-cube Bispecific Antibody Platform) has received a U.S. patent.
Antibodies For T-Cell Activation' has been granted a U.S. invention patent, Certificate No. 11,725,058.
09.04 2023
Antibodies for T-Cell Activation (T-cube Bispecific Antibody Platform) has received a U.S. patent.
Antibodies For T-Cell Activation' has been granted a U.S. invention patent, Certificate No. 11,725,058.
建議您使用以下瀏覽器觀看本網站,
以獲得最佳瀏覽效果。